These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30925337)

  • 1. Discovery of novel bacterial FabH inhibitors (Pyrazol-Benzimidazole amide derivatives): Design, synthesis, bioassay, molecular docking and crystal structure determination.
    Wang YT; Shi TQ; Fu J; Zhu HL
    Eur J Med Chem; 2019 Jun; 171():209-220. PubMed ID: 30925337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
    Zhang F; Wen Q; Wang SF; Shahla Karim B; Yang YS; Liu JJ; Zhang WM; Zhu HL
    Bioorg Med Chem Lett; 2014 Jan; 24(1):90-5. PubMed ID: 24332628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and antimicrobial activities evaluation of Schiff base derived from secnidazole derivatives as potential FabH inhibitors.
    Li Y; Zhao CP; Ma HP; Zhao MY; Xue YR; Wang XM; Zhu HL
    Bioorg Med Chem; 2013 Jun; 21(11):3120-6. PubMed ID: 23602519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and molecular docking of 1,4-benzodioxane thiazolidinedione piperazine derivatives as FabH inhibitors.
    Sun J; He W; Liu HY; Qin J; Ye CL
    Bioorg Chem; 2019 Jul; 88():102958. PubMed ID: 31054434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Wang XL; Zhang YB; Tang JF; Yang YS; Chen RQ; Zhang F; Zhu HL
    Eur J Med Chem; 2012 Nov; 57():373-82. PubMed ID: 23124163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of chrysin derivatives as potential FabH inhibitors.
    Li HX; Wang ZC; Qian YM; Yan XQ; Lu YD; Zhu HL
    Chem Biol Drug Des; 2017 Jan; 89(1):136-140. PubMed ID: 27860280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antibacterial activity of cinnamaldehyde acylhydrazone with a 1,4-benzodioxan fragment as a novel class of potent β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitor.
    Song X; Yang Y; Zhao J; Chen Y
    Chem Pharm Bull (Tokyo); 2014; 62(11):1110-8. PubMed ID: 25196128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of Arylsulfonylhydrazones as Potential FabH Inhibitors: Synthesis, Antimicrobial Evaluation and Molecular Docking.
    Fernandes TB; Segretti ND; Lourenço FR; Cândido TM; Baby AR; Barbosa EG; Parise-Filho R
    Med Chem; 2021; 17(5):474-484. PubMed ID: 31763975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
    Shi L; Fang RQ; Zhu ZW; Yang Y; Cheng K; Zhong WQ; Zhu HL
    Eur J Med Chem; 2010 Sep; 45(9):4358-64. PubMed ID: 20557983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea.
    Zhang HJ; Qin X; Liu K; Zhu DD; Wang XM; Zhu HL
    Bioorg Med Chem; 2011 Sep; 19(18):5708-15. PubMed ID: 21872479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
    Li JR; Li DD; Wang RR; Sun J; Dong JJ; Du QR; Fang F; Zhang WM; Zhu HL
    Eur J Med Chem; 2014 Mar; 75():438-47. PubMed ID: 24561667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combine approach of chemical synthesis, biological evaluation and structural dynamics studies revealed thiazole substituted arylamine derivatives as potent FabH enzyme inhibitors.
    Ahmad H; Ahmad F; Parveen S; Ahmad S; Azam SS; Hassan A
    Bioorg Chem; 2020 Dec; 105():104426. PubMed ID: 33161255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel dinitrobenzotrifluoride containing o-hydroxybenzylamine derivatives as potential antibacterial agents.
    Li QS; Ni HJ; Yang Y; Lv XH; Ruan BF
    Med Chem; 2015; 11(3):305-13. PubMed ID: 25219926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis and Antibacterial Activities of Novel Amide Derivatives Bearing Dioxygenated Rings as Potential β-Ketoacyl-acyl Carrier Protein Synthase III (FabH) Inhibitors.
    Zhou Y; Liang YQ; Wang XY; Chang HY; Hu SP; Sun J
    Chem Pharm Bull (Tokyo); 2022; 70(8):544-549. PubMed ID: 35908920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of 2-styryl of 5-Nitroimidazole derivatives and antimicrobial activities as FabH inhibitors.
    Duan YT; Wang ZC; Sang YL; Tao XX; Teraiya SB; Wang PF; Wen Q; Zhou XJ; Ding L; Yang YH; Zhu HL
    Eur J Med Chem; 2014 Apr; 76():387-96. PubMed ID: 24594526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a new binding site in E. coli FabH using Molecular dynamics simulations: validation by computational alanine mutagenesis and docking studies.
    Ramamoorthy D; Turos E; Guida WC
    J Chem Inf Model; 2013 May; 53(5):1138-56. PubMed ID: 23581389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New antibacterial agents: Hybrid bioisoster derivatives as potential E. coli FabH inhibitors.
    Segretti ND; Serafim RA; Segretti MC; Miyata M; Coelho FR; Augusto O; Ferreira EI
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3988-93. PubMed ID: 27426865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target identification, and optimization of dioxygenated amide derivatives as potent antibacterial agents with FabH inhibitory activity.
    Chang H; Ji R; Zhu Z; Wang Y; Yan S; He D; Jia Q; Huang P; Cheng T; Wang R; Zhou Y
    Eur J Med Chem; 2024 Feb; 265():116064. PubMed ID: 38159483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors.
    Qin YJ; Wang PF; Makawana JA; Wang ZC; Wang ZN; Yan-Gu ; Jiang AQ; Zhu HL
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5279-83. PubMed ID: 25587588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
    Lv PC; Sun J; Luo Y; Yang Y; Zhu HL
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4657-60. PubMed ID: 20594840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.